SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
NanoViricides, Inc. Reports That Oral Administration of FluCide® Anti-Influenza Drug Candidates Led to Survival Improvements Comparable to IV Administration and Was Far Superior to Oseltamivir, in a Highly Lethal Animal Model